Latest News in the pharma Industry

Research & Development

European Commission approves BMS's Opdivo for Hodgkin's

European Commission approves BMS's Opdivo for Hodgkin's

24 Nov 2016

Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union.

Read more 
Hopes dashed for new Alzheimer drug

Hopes dashed for new Alzheimer drug

23 Nov 2016

Lilly's solanezumab fails to meet primary endpoint of Phase III study.

Read more 
Allergan boosts its CNS pipeline with acquisition

Allergan boosts its CNS pipeline with acquisition

23 Nov 2016

Chase acquisition adds a new Phase III ready program for Alzheimer's disease to Allergan portfolio.

Read more 
New asthma treatments on the horizon?

New asthma treatments on the horizon?

22 Nov 2016

Studies suggest calcilytics may represent effective future asthma therapeutics.

Read more 
Oxford Genetics receives grant to create virus packaging cell lines

Oxford Genetics receives grant to create virus packaging cell lines

21 Nov 2016

Grant will be used to tackle one of the biggest bioproduction problems currently facing the industry

Read more 
Novartis acquires Selexys Pharmaceuticals and SelG1 antibody for reduction of pain crises in SCD

Novartis acquires Selexys Pharmaceuticals and SelG1 antibody for reduction of pain crises in SCD

21 Nov 2016

Deal followed results of Phase II SUSTAIN study of SelG1 in reduction of vaso-occlusive pain crises, a major complication of SCD with limited treatment options.

Read more 
Intarcia's NDA tackles glycemic control and poor patient adherence head on

Intarcia's NDA tackles glycemic control and poor patient adherence head on

21 Nov 2016

ITCA 650 is the first investigational drug to use Intarcia's disruptive Medici Drug Delivery System to deliver chronic medicines just once or twice yearly.

Read more 
Amgen's erenumab significantly reduces monthly migraine days in patients with episodic migraine

Amgen's erenumab significantly reduces monthly migraine days in patients with episodic migraine

20 Nov 2016

Second Phase III study confirms results from previous studies.

Read more 
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin

Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin

20 Nov 2016

BI 695502 met all the pre-defined primary and secondary endpoints in the INVICTAN-1 study.

Read more 
CSL Behring presents positive results from CSL112 Phase IIb trial

CSL Behring presents positive results from CSL112 Phase IIb trial

16 Nov 2016

CSL112 is being developed to reduce the high incidence of early recurrent cardiovascular events.

Read more 
Repatha regresses atherosclerosis in patients with coronary artery disease

Repatha regresses atherosclerosis in patients with coronary artery disease

15 Nov 2016

Nearly two-thirds of patients experienced plaque regression with Repatha on top of optimized statin therapy.

Read more 
GSK announces positive results in fourth consecutive pivotal trial of Benlysta in SLE

GSK announces positive results in fourth consecutive pivotal trial of Benlysta in SLE

14 Nov 2016

Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta.

Read more